Annual Total Debt
$3.56 M
-$568.00 K-13.77%
December 31, 2023
Summary
- As of March 13, 2025, MTNB annual total debt is $3.56 million, with the most recent change of -$568.00 thousand (-13.77%) on December 31, 2023.
- During the last 3 years, MTNB annual total debt has fallen by -$194.10 thousand (-5.18%).
- MTNB annual total debt is now -24.39% below its all-time high of $4.70 million, reached on December 31, 2021.
Performance
MTNB Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$3.07 M
-$170.00 K-5.25%
September 30, 2024
Summary
- As of March 13, 2025, MTNB quarterly total debt is $3.07 million, with the most recent change of -$170.00 thousand (-5.25%) on September 30, 2024.
- Over the past year, MTNB quarterly total debt has dropped by -$637.00 thousand (-17.18%).
- MTNB quarterly total debt is now -36.46% below its all-time high of $4.83 million, reached on September 30, 2021.
Performance
MTNB Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
MTNB Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.8% | -17.2% |
| 3 y3 years | -5.2% | -17.2% |
| 5 y5 years | +809.9% | -17.2% |
MTNB Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.4% | at low | -34.7% | at low |
| 5 y | 5-year | -24.4% | at low | -36.5% | at low |
| alltime | all time | -24.4% | -100.0% | -36.5% | -100.0% |
Matinas BioPharma Holdings Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.07 M(-5.2%) |
| Jun 2024 | - | $3.24 M(-4.6%) |
| Mar 2024 | - | $3.40 M(-4.4%) |
| Dec 2023 | $3.56 M(-13.8%) | $3.56 M(-4.1%) |
| Sep 2023 | - | $3.71 M(-3.8%) |
| Jun 2023 | - | $3.85 M(-3.4%) |
| Mar 2023 | - | $3.99 M(-3.3%) |
| Dec 2022 | $4.12 M(-12.3%) | $4.12 M(-2.5%) |
| Sep 2022 | - | $4.23 M(-4.6%) |
| Jun 2022 | - | $4.43 M(-3.0%) |
| Mar 2022 | - | $4.57 M(-2.8%) |
| Dec 2021 | $4.70 M(+25.4%) | $4.70 M(-2.7%) |
| Sep 2021 | - | $4.83 M(+37.6%) |
| Jun 2021 | - | $3.51 M(-3.1%) |
| Mar 2021 | - | $3.63 M(-3.3%) |
| Dec 2020 | $3.75 M(-11.3%) | $3.75 M(-3.1%) |
| Sep 2020 | - | $3.87 M(-3.0%) |
| Jun 2020 | - | $3.99 M(-2.9%) |
| Mar 2020 | - | $4.11 M(-2.8%) |
| Dec 2019 | $4.23 M(+982.0%) | $4.23 M(-2.7%) |
| Sep 2019 | - | $4.35 M(-2.5%) |
| Jun 2019 | - | $4.46 M(-4.0%) |
| Mar 2019 | - | $4.65 M(+1088.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $390.80 K(+47.5%) | $390.80 K(-25.7%) |
| Sep 2018 | - | $525.70 K(+237.6%) |
| Jun 2018 | - | $155.70 K(-26.0%) |
| Mar 2018 | - | $210.30 K(-20.6%) |
| Dec 2017 | $264.90 K(+83.4%) | $264.90 K(-27.4%) |
| Sep 2017 | - | $364.80 K(+419.7%) |
| Jun 2017 | - | $70.20 K(-1.4%) |
| Mar 2017 | - | $71.20 K(-50.7%) |
| Dec 2016 | $144.40 K(+1177.9%) | $144.40 K(-33.6%) |
| Sep 2016 | - | $217.60 K(+618.2%) |
| Jun 2016 | - | $30.30 K(>+9900.0%) |
| Mar 2016 | - | $0.00(-100.0%) |
| Dec 2015 | $11.30 K(-81.1%) | $11.30 K(-65.2%) |
| Sep 2015 | - | $32.50 K(-25.5%) |
| Jun 2015 | - | $43.60 K(-20.1%) |
| Mar 2015 | - | $54.60 K(-8.5%) |
| Dec 2014 | $59.70 K(>+9900.0%) | $59.70 K(-10.4%) |
| Sep 2014 | - | $66.60 K(-14.0%) |
| Jun 2014 | - | $77.40 K(-12.1%) |
| Mar 2014 | - | $88.10 K(>+9900.0%) |
| Dec 2013 | $0.00 | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00 |
FAQ
- What is Matinas BioPharma Holdings annual total debt?
- What is the all time high annual total debt for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings annual total debt year-on-year change?
- What is Matinas BioPharma Holdings quarterly total debt?
- What is the all time high quarterly total debt for Matinas BioPharma Holdings?
- What is Matinas BioPharma Holdings quarterly total debt year-on-year change?
What is Matinas BioPharma Holdings annual total debt?
The current annual total debt of MTNB is $3.56 M
What is the all time high annual total debt for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high annual total debt is $4.70 M
What is Matinas BioPharma Holdings annual total debt year-on-year change?
Over the past year, MTNB annual total debt has changed by -$568.00 K (-13.77%)
What is Matinas BioPharma Holdings quarterly total debt?
The current quarterly total debt of MTNB is $3.07 M
What is the all time high quarterly total debt for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly total debt is $4.83 M
What is Matinas BioPharma Holdings quarterly total debt year-on-year change?
Over the past year, MTNB quarterly total debt has changed by -$637.00 K (-17.18%)